Literature DB >> 28222835

Clinical Assessment of Urinary Tract Damage during Sustained-Release Estrogen Supplementation in Mice.

Dalis E Collins1, Kathleen R Mulka2, Mark J Hoenerhoff3, Russell S Taichman4, Jason S Villano5.   

Abstract

Estrogen supplementation is a key component of numerous mouse research models but can adversely affect the urinary system. The goal of this study was to develop a clinical scoring system and identify biomarkers of occult urinary tract lesions prior to the development of systemic illness in mice. Ovariectomized or sham-surgery SCID mice were implanted subcutaneously with a placebo pellet or one containing sustained-release estradiol (0.18 mg 60-d release 17β-estradiol). Mice were assessed twice weekly for 4 to 6 wk by using a clinical scoring system that included body condition, general activity, posture, hair coat, hydration, abdominal distension, urine staining of coat and skin, and ability to urinate. Samples were collected weekly for urinalysis, BUN, creatinine, and serum estradiol levels. Terminal samples were analyzed for histopathologic lesions. Compared with placebo controls, estradiolsupplemented mice had higher serum estradiol levels at weeks 2 and 3; significant differences in total clinical scores by the 3-wk time point; and in body condition, general activity, posture, hair coat, and urine staining scores by the 6-wk terminal time point. Urinary tract lesions included hydronephrosis, pyelonephritis, cystitis, and urolithiasis. All mice with urolithiasis had crystalluria, and 5 of the 6 mice with pyelonephritis or hydroureter had dilute urine (that is, specific gravity less than 1.030). However, these findings were not specific to mice with lesions. A total clinical score of 3.5 (maximum, 24) identified estradiol-supplemented mice with 83% specificity and 50% sensitivity, but no single clinical parameter, biomarker, or the total clinical score accurately predicted occult urinary tract lesions. Considering the lesions we observed, prudence is warranted when using pelleted sustained-release estradiol in mice, and important parameters to monitor for animal health include urine staining, body condition score, urine sediment, and urine specific gravity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28222835      PMCID: PMC5310620     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  44 in total

1.  Estimation of estradiol in mouse serum samples: evaluation of commercial estradiol immunoassays.

Authors:  Daniel J Haisenleder; Aleisha H Schoenfelder; Elizabeth S Marcinko; Lisa M Geddis; John C Marshall
Journal:  Endocrinology       Date:  2011-09-20       Impact factor: 4.736

2.  Safe and effective method for chronic 17beta-estradiol administration to mice.

Authors:  Justine A Levin-Allerhand; Karen Sokol; Jonathan D Smith
Journal:  Contemp Top Lab Anim Sci       Date:  2003-11

3.  Local Effects of Vaginally Administered Estrogen Therapy: A Review.

Authors:  Megan Krause; Thomas L Wheeler; Thomas E Snyder; Holly E Richter
Journal:  J Pelvic Med Surg       Date:  2009-05

4.  Order of magnitude differences between methods for maintaining physiological 17beta-oestradiol concentrations in ovariectomized rats.

Authors:  Jakob O Ström; Elvar Theodorsson; Annette Theodorsson
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

5.  Substantial discrepancies in 17beta-oestradiol concentrations obtained with three different commercial direct radioimmunoassay kits in rat sera.

Authors:  Jakob O Ström; Annette Theodorsson; Elvar Theodorsson
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

6.  Interstrain differences in the development of pyometra after estrogen treatment of rats.

Authors:  Lisa Jane Brossia; Christopher Sean Roberts; Jennifer T Lopez; Robert M Bigsby; Joseph R Dynlacht
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-09       Impact factor: 1.232

7.  Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression.

Authors:  Xavier Gamé; Julien Allard; Ghislaine Escourrou; Pierre Gourdy; Ivan Tack; Pascal Rischmann; Jean-François Arnal; Bernard Malavaud
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-01-09       Impact factor: 3.619

8.  Muscarinic receptors mediating contraction of female mouse urinary bladder: effects of oestrogen.

Authors:  Sherie Ma; Margot E Story; Jocelyn N Pennefather
Journal:  Eur J Pharmacol       Date:  2004-03-08       Impact factor: 4.432

9.  Symmetric Dimethylarginine Assay Validation, Stability, and Evaluation as a Marker for the Early Detection of Chronic Kidney Disease in Dogs.

Authors:  M B Nabity; G E Lees; M M Boggess; M Yerramilli; E Obare; M Yerramilli; A Rakitin; J Aguiar; R Relford
Journal:  J Vet Intern Med       Date:  2015-06-16       Impact factor: 3.333

10.  Novel, low cost, highly effective, handmade steroid pellets for experimental studies.

Authors:  Ana Sahores; Guillermina M Luque; Victoria Wargon; María May; Alfredo Molinolo; Damasia Becu-Villalobos; Claudia Lanari; Caroline A Lamb
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more
  6 in total

Review 1.  Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.

Authors:  Timothy K Cooper; David K Meyerholz; Amanda P Beck; Martha A Delaney; Alessandra Piersigilli; Teresa L Southard; Cory F Brayton
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

2.  Identifying and Implementing Endpoints for Geriatric Mice.

Authors:  Linda A Toth
Journal:  Comp Med       Date:  2018-11-28       Impact factor: 0.982

3.  Staphylococcus xylosus Cystitis and Struvite Urolithiasis in Nude Mice Implanted with Sustained-release Estrogen Pellets.

Authors:  Kenneth J Salleng; Carissa P Jones; Kelli L Boyd; Donna J Hicks; Michelle M Williams; Rebecca S Cook
Journal:  Comp Med       Date:  2018-07-17       Impact factor: 0.982

4.  Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice.

Authors:  Amy Christensen; Christian J Pike
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

Review 5.  Male Lower Urinary Tract Dysfunction: An Underrepresented Endpoint in Toxicology Research.

Authors:  Nelson T Peterson; Chad M Vezina
Journal:  Toxics       Date:  2022-02-16

6.  Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers.

Authors:  Yutian Feng; Rebecca Meshaw; Darryl McDougald; Zhengyuan Zhou; Xiao-Guang Zhao; Stephen A Jannetti; Robert E Reiman; Erica Pippen; Robin Marjoram; Jeffrey L Schaal; Ganesan Vaidyanathan; Michael R Zalutsky
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.